SCHEMBL29323704

SCHEMBL29323704

COC(=O)c1ccc(-c2cnccn2)c2c1NCCO2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
HTT P42858 2/20 0.36
HSD17B10 Q99714 1/20 0.36
ALDH1A1 P00352 2/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
CYP11B2 P19099 1/20 0.36
CYP46A1 Q9Y6A2 1/20 0.35
SSTR4 P31391 1/20 0.35
CSNK2A1 P68400 1/20 0.34
MAP4K1 Q92918 2/20 0.34
ABL1 P00519 1/20 0.34
MAP2K1 Q02750 1/20 0.33
KMT2A Q03164 1/20 0.33
RAB9A P51151 1/20 0.33
RET P07949 1/20 0.33
PIK3CA P42336 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31056919 0.85 KDM4E (0.40) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL29321031 0.85 KDM4E (0.40) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL29324065 0.83 KDM4E (0.35) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL31056909 0.83 KDM4E (0.35) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL29323701 0.76 KDM4E (0.36) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL22460281 0.72 KDM4E (0.43) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL11296276 0.71 KDM4E (0.51) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL29279278 0.70 KMT2A (0.55) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL30336285 0.70 KMT2A (0.55) KDM4EHTTHSD17B10ALDH1A1GLA
SCHEMBL21955273 0.70 KDM4E (0.35) KDM4EHTTHSD17B10ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed